S2284 Risk of De Novo Gastroparesis in Pre- and Peri-Menopause, Non-Obese Females on Progestogen-Only Contraceptives Versus Combined OCP: A Multi-Center Analysis

Do Han Kim,Donghyun Ko,Sharon Narvaez,Luis Nieto,Pedro Palacios-Argueta,Paul Kroner,Frank J. Lukens
DOI: https://doi.org/10.14309/01.ajg.0001038504.49440.d6
2024-10-26
The American Journal of Gastroenterology
Abstract:There is evidence suggesting that oral contraceptive pills (OCP) may stabilize gastroparesis symptoms associated with hormonal fluctuations. Progesterone has been shown to slow gastrointestinal motility in a dose-dependent manner, theoretically worsening gastroparesis symptoms. However, this association has not been studied. The aim of this study is to assess the risk of de novo gastroparesis in pre- and peri-menopause, non-obese females on progestogen-onlycontraceptives versus combined OCP.
gastroenterology & hepatology
What problem does this paper attempt to address?